Breast cancer is known to be mainly caused by the estrogen signal and the human epithelial growth factor receptor 2 (HER2) signal. Patients overexpressing HER2 have a significantly lower survival rate and overexpression of HER2 in breast tissue ...
박상수
core +1 more source
Design, Characterization, and Evaluation of scFvCD133/rGelonin: A CD133-Targeting Recombinant Immunotoxin for Use in Combination with Photochemical Internalization. [PDF]
Olsen CE +6 more
europepmc +1 more source
Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro. [PDF]
Deng C +8 more
europepmc +1 more source
Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin. [PDF]
King EM +5 more
europepmc +1 more source
Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges. [PDF]
Zhu S, Liu Y, Wang PC, Gu X, Shan L.
europepmc +1 more source
HER2-specific recombinant immunotoxin 4D5scFv-PE40 passes through retrograde trafficking route and forces cells to enter apoptosis. [PDF]
Sokolova E +5 more
europepmc +1 more source
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors. [PDF]
Mazor R +7 more
europepmc +1 more source
Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38. [PDF]
Mazor R +6 more
europepmc +1 more source
Discovery and Optimization of the Novel Immunotoxins Targeting TROP2 for Cancer Therapy. [PDF]
Li J +10 more
europepmc +1 more source
Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity. [PDF]
Mazor R +7 more
europepmc +1 more source

